SavedAdd your journal

Journals / Batı Karadeniz Tıp Dergisi / 2022 / Cilt: 6 - Sayı: 2

The Value of Indirect Biomarkers in the Monitoring of Hepatitis C Virus Infection at the Mogadishu Hospital, Somalia

Somali Mogadişu Hastanesinde Hepatit C Virüsü Enfeksiyonunun İzlenmesinde Dolaylı Biyobelirteçlerin Değeri

Öznur SARI
Pages
158–164
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The anti-HCV positivity rate was found to be 1.5 times higher in men than women.APRI, MPV / Plt R and RPR levels, indirect markers of liver damage, were found to be higher in patients with anti-HCV (+) than those in the control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to investigate the value of Class II fibrosis markers as predictors of liver disease progress, and changes in platelet parameters in the laboratory tests of patients with Hepatitis C virus infection [anti-HCV (+)]admitted to the Somalia Mogadishu Hospital.
📊
Key Findings & Data:Material and Methods: All patients older than 18 years old, who were examined in our hospital’s were included in the study.
💡
Conclusion & Impact:The anti-HCV positivity rate was found to be 1.5 times higher in men than women.APRI, MPV / Plt R and RPR levels, indirect markers of liver damage, were found to be higher in patients with anti-HCV (+) than those in the control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to investigate the value of Class II fibrosis markers as predictors of liver disease progress, and changes in platelet parameters in the laboratory tests of patients with Hepatitis C virus infection [anti-HCV (+)]admitted to the Somalia Mogadishu Hospital. Material and Methods: All patients older than 18 years old, who were examined in our hospital’s were included in the study. Accompanied by CBC and biochemical measurement results from patients, indirect liver fibrosis (Class II) markers AAR (AST/ALT ratio), APRI (AST/Plt ratio index) and FIB-4 index (Age (year) x AST (U/L) / [Platelet count (109 / L)] x (ALT) 1/2 (U / L)], MPV/Platelet ratio, APRI = [(person AST/AST reference upper limit) x Platelet (103 /ml) x 100] were calculated. Results: A total of 2,887 patients, 1,605 (55.6%) male and 1,282 (44.4%) female, with a median age of 51 (32-67) years, were included in our study. The anti-HCV positivity rate was found to be 1.5 times higher in men than women.APRI, MPV / Plt R and RPR levels, indirect markers of liver damage, were found to be higher in patients with anti-HCV (+) than those in the control group (p

Özet

Amaç: Somali Mogadişu Hastanesi’ne başvuran Hepatit C virüsü enfeksiyonu [anti-HCV (+)] olan hastaların laboratuvar testlerinde, karaciğer hastalığının ilerlemesini öngören Sınıf II fibrozis belirteçlerinin değerini ve trombosit parametrelerindeki değişiklikleri araştırmayı amaçladık. Gereç ve Yöntemler: Hastanemizde muayene edilen 18 yaş üstü tüm hastalar çalışmaya dahil edildi. CBC ve hastalardan alınan biyokimyasal ölçüm sonuçları eşliğinde, dolaylı karaciğer fibrozu (Sınıf II) belirteçleri AAR (AST/ALT oranı), APRI (AST/Plt oran indeksi) ve FIB-4 indeksi (Yaş (yıl) x AST (U/L) ) / [Platelet sayısı (109 / L)] x (ALT) 1/2 (U / L)], MPV/Platelet oranı, APRI = [(kişi AST/AST referans üst limiti) x Trombosit (103 /ml) x 100] hesaplandı. Bulgular: Çalışmamıza medyan yaşı 51 (32-67) yıl olan 1.605 (%55.6) erkek ve 1.282 (%44.4) kadın olmak üzere toplam 2.887 hasta dahil edildi. Erkeklerde anti-HCV pozitiflik oranı kadınlara göre 1,5 kat daha yüksek bulundu. Karaciğer hasarının dolaylı belirteçleri olan APRI, MPV / Plt R ve RPR düzeyleri, anti-HCV (+) olan hastalarda kontrol grubuna göre daha yüksek bulundu (p

🔖

Cite This Article

SARI, Ö. (2022). The Value of Indirect Biomarkers in the Monitoring of Hepatitis C Virus Infection at the Mogadishu Hospital, Somalia. Batı Karadeniz Tıp Dergisi, Cilt: 6 - Sayı: 2, 158–164. https://ajindex.com/articles/463044

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: Considerations for healthcare providers in the United States. Clin Infect Dis 2012;55(suppl_1):S10-15
  2. Daw MA, Dau AA. Hepatitis C virus in Arab world: A state of concern. Scientific World Journal 2012;2012:719494
  3. Hassan-Kadle MA, Osman MS, Ogurtsov PP. Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study. World J Gastroenterol 2018;24(34):3927-3957
  4. Loggi E, Vukotic R, Conti F, Gitto S, Andreone P. Gold standard assays for the monitoring of patients with chronic hepatitis C. Future Virol 2018;13(8):529-537
  5. Misdraji J. Changing indications for liver biopsy: Viral hepatitis. Diagnostic Histopathol 2014;20(3):119-124
  6. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003;163(2):218-224
  7. Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, Erdem H, Oncul O, Gorenek L. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Eur J Gastroenterol Hepatol 2014;26(12):1320- 1324
  8. Shao LN, Zhang ST, Wang N, Yu WJ, Chen M, Xiao N, Duan Y, Pan LZ, Song WQ, Xia YX, Zhang L, Qi N, Liu M, Zhou SH. Platelet indices significantly correlate with liver fibrosis in HCV- infected patients. PLoS One. 2020;15(1):e0227544
  9. Eminler AT, Ayyildiz T, Irak K, Kiyici M, Gurel S, Dolar E, Gulten M, Nak SG. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients. Eur J Gastroenterol Hepatol 2015;27(12):1361-1366
  10. Guéchot J, Boisson RC, Zarski J-P, Sturm N, Calès P, Lasnier E. AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations. Clin Res Hepatol Gastroenterol 2013;37(5):467-472
  11. Haklar G. Liver function tests in chronic viral hepatitis cases. Marmara Med J 2016;29(4):6
  12. Reedy DW, Loo AT, Levine RA. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C. Dig Dis Sci 1998;43(9):2156-2159
  13. Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Dar